Upload
anon180814140
View
3
Download
0
Embed Size (px)
Citation preview
Vol. 17 No. 5 2015Health Systems in Transition
Jonathan Cylus Erica RichardsonLisa Findley Marcus LongleyCiaran O'Neill David Steel
Jonathan Cylus and Erica Richardson (Editors) and Ellen Nolte and Ewout van Ginneken (Series editors) were responsible for this HiTEditorial Board
Series editorsReinhard Busse, Berlin University of Technology, GermanyJosep Figueras, European Observatory on Health Systems and PoliciesMartin McKee, London School of Hygiene & Tropical Medicine, United KingdomElias Mossialos, London School of Economics and Political Science, United KingdomEllen Nolte, European Observatory on Health Systems and PoliciesEwout van Ginneken, Berlin University of Technology, GermanySeries coordinatorGabriele Pastorino, European Observatory on Health Systems and PoliciesEditorial teamJonathan Cylus, European Observatory on Health Systems and PoliciesCristina Hernndez-Quevedo, European Observatory on Health Systems and PoliciesMarina Karanikolos, European Observatory on Health Systems and PoliciesAnna Maresso, European Observatory on Health Systems and PoliciesDavid McDaid, European Observatory on Health Systems and PoliciesSherry Merkur, European Observatory on Health Systems and PoliciesDimitra Panteli, Berlin University of Technology, GermanyWilm Quentin, Berlin University of Technology, GermanyBernd Rechel, European Observatory on Health Systems and PoliciesErica Richardson, European Observatory on Health Systems and PoliciesAnna Sagan, European Observatory on Health Systems and PoliciesAnne Spranger, Berlin University of Technology, GermanyInternational advisory boardTit Albreht, Institute of Public Health, SloveniaCarlos Alvarez-Dardet Daz, University of Alicante, SpainRifat Atun, Harvard University, United StatesJohan Calltorp, Nordic School of Public Health, SwedenArmin Fidler, The World BankColleen Flood, University of Toronto, CanadaPter Gal, Semmelweis University, HungaryUnto Hkkinen, Centre for Health Economics at Stakes, FinlandWilliam Hsiao, Harvard University, United StatesAllan Krasnik, University of Copenhagen, DenmarkJoseph Kutzin, World Health OrganizationSoonman Kwon, Seoul National University, Republic of KoreaJohn Lavis, McMaster University, CanadaVivien Lin, La Trobe University, AustraliaGreg Marchildon, University of Regina, CanadaAlan Maynard, University of York, United KingdomNata Menabde, World Health OrganizationCharles Normand, University of Dublin, IrelandRobin Osborn, The Commonwealth Fund, United StatesDominique Polton, National Health Insurance Fund for Salaried Staff (CNAMTS), FranceSophia Schlette, Federal Statutory Health Insurance Physicians Association, GermanyIgor Sheiman, Higher School of Economics, Russian FederationPeter C. Smith, Imperial College, United KingdomWynand P.M.M. van de Ven, Erasmus University, The NetherlandsWitold Zatonski, Marie Sklodowska-Curie Memorial Cancer Centre, Poland
Health Systems in TransitionJonathan Cylus, European Observatory on Health Systems and PoliciesEr ica Richardson, European Observatory on Health Systems and PoliciesLisa Findley, Editorial ConsultantMarcus Longley, Welsh Institute for Health and Social Care, University of South WalesCiaran ONeill, NUI Galway and Queens University Belfast David Steel, University of Aberdeen, (formerly Chief Executive, NHS Quality Improvement Scotland)
Health System Review2015
United Kingdom:
The European Observatory on Health Systems and Policies is a partnership between the HO Reional Oice or Europe the overnments o ustria elium inland reland orway Slovenia Sweden the nited indom and the eneto Reion o taly the European ommission the orld an rench ational nion o Health nsurance unds the ondon School o Economics and Political Science and the ondon School o Hyiene Tropical edicine The European Observatory has a secretariat in russels and it has hubs in ondon at SE and SHT and at the Technical niversity o erlin
Keywords:
World Health Organization 2015 (acting as the host organization for, and secretariat of, the European Observator on Health stes and olicies
ll rihts reserved The European Observatory on Health Systems and Policies welcomes reuests or permission to reproduce or translate its publications in part or in ull
Please address reuests about the publication to ublications, WHO egional Office for Europe, i t, arorve 51, 2100 openhagen , enar
lternatively complete an online reuest orm or documentation health inormation or or permission to uote or translate on the Reional Oice web site httpwwweurowhointenwhatwepublishpublicationreuestorms
The views epressed by authors or editors do not necessarily represent the decisions or the stated policies o the European Observatory on Health Systems and Policies or any o its partners
The desinations employed and the presentation o the material in this publication do not imply the epression o any opinion whatsoever on the part o the European Observatory on Health Systems and Policies or any o its partners concernin the leal status o any country territory city or area or o its authorities or concernin the delimitation o its rontiers or boundaries here the desination country or area appears in the headins o tables it covers countries territories cities or areas otted lines on maps represent approimate border lines or which there may not yet be ull areement
The mention o speciic companies or o certain manuacturers products does not imply that they are endorsed or recommended by the European Observatory on Health Systems and Policies in preerence to others o a similar nature that are not mentioned Errors and omissions ecepted the names o proprietary products are distinuished by initial capital letters
The European Observatory on Health Systems and Policies does not warrant that the inormation contained in this publication is complete and correct and shall not be liable or any damaes incurred as a result o its use
Printed and bound in the nited indom
11 12 ol 1 o 5
Suggested citation:
Health Systems in Transition
Contents
Preface vAcknowledgements viiList of abbreviations ixList of tables and figures xiiiAbstract xvExecutive summary xvii
1 Introduction 1
Organization and governance 13
3 Financing 41
4 Physical and human resources 63
5 Provision of ser vices 77
6 Pr incipal health reforms 99
7 Assessment of the health system 105
8 Conclusions 113
9 Appendices 115
Preface
Acknowledgements
List of abbreviations
bbreviation
P ny ualiied Provider
ritish ental ssociation
ritish edical ssociation
PT est Practice Taris
S ritish Social ttitudes survey
omplementary and lternative edicines
linical ommissionin roup
H ommunity Health ouncil
HP ommunity Health Partnerships
ompetition and arets uthority
OP hronic Obstructive Pulmonary isease
P ontinuin Proessional evelopment
are uality ommission
ommissionin or uality and nnovation
S ommissionin Support nit
isability dusted ie ears
R octors and entists Remuneration Review ody
H epartment o Health
HSSPS epartment o Health Social Services and Public Saety
ET Electroconvulsive Therapy
EE European Economic rea
E European edicines ency
EPS Electronic Prescription Service
E European nion
O reedom o normation
T oundation Trust
eneral ental ouncil
P ross omestic Product
eneral edical ouncil
bbreviation
S eneral edical Services
P eneral Practitioner
Ph eneral Pharmaceutical ouncil
HET Health improvement Eiciency ccess Treatment
HS Healthcare mprovement Scotland
H Healthcare nspectorate ales
H Healthy ie Epectancy
HR Her aestys Revenue and ustoms
HR Healthcare Resource roup
HS Health and Social are ct 2012
HS Health and Social are normation entre
HT Health Technoloy ssessment
iTPP nnovative Technoloy doption Procurement Proramme
ocal ommissionin roup
H ocal Health oard
aret orces actor
HR edicines and Healthcare products Reulatory ency
P ember o Parliament
P inimum Practice ncome uarantee
HS ational Health Service
ational nsurance ontributions
E ational nstitute or Health and are ormerly linical Ecellence
PT ational Proramme or normation Technoloy
S ational Screenin ommittee
SE ational Service ser Eperience
OE Oranisation or Economic ooperation and evelopment
OS Oice or ational Statistics
OOH Outohours
OT Over the ounter
PP Pay or Perormance
PS Picture rchivin and ommunications Systems
PS Patient dvice and iaison Service
PaS Procurement and oistics Service
PbR Payment by Results
PT Primary are Trust
P Public ividend apital
P Private inance nitiative
PS Personal edical Services
PO Prescription Only edicines
PP Personal and Public nvolvement
bbreviation
PPE Public Patient nvolvement Eperience
PPP Public Private Partnership
PPRS Pharmaceutical Price Reulation Scheme
PS Public Service reements
PS Public Services oards
R Royal ollee o ursin
R Reulation and uality mprovement uthority
RTT Reerral to Treatment
SH Strateic Health uthority
S Strateic nvestment oard
S Scottish edicines onsortium
T Tuberculosis
T Trust evelopment uthority HS
nits o ental ctivity
nited ations
H oluntary Health nsurance
HO orld Health Oraniation
TO orld Trade Oraniation
ears o ie ost
List of tables and figures
Tables paeTable 11 Trends in populationdemoraphic indicators selected years
Table 12 acroeconomic indicators selected years 5
Table 1 ortality and health indicators selected years
Table 1 Healthy years o lie
Table 15 Standardied death rates selected years
Table 1 orbidity and actors aectin health status selected years 10
Table 1 aternal child and adolescent health indicators selected years 11
Table 1 Trends in health ependiture in the nited indom 15 to 201
Table 1 ianostic imain in the nited indom 2012
Figures paei 11 ap o the nited indom 2
i 21 Overview o the health system 15
i 1 Health ependiture as a share o P in the HO European Reion latest available year
i 2 Total health ependiture as o P HO estimates 5
i Health ependiture in PPP per capita in the HO European Reion latest available year
i Health ependiture rom public sources as a percentae o total health ependiture in the HO European Reion latest available year
i 5 inancial lows
i 1 Hospital beds by type per 100 000 population 200 200 and 201
i 2 cute care hospital beds per 100 000 population
i verae lenth o stay acute care hospitals only
i Physicians per 100 000 population 0
i 5 urses per 100 000 population 1
i Physicians and nurses per 100 000 population 2
i entists per 100 000 population
i Pharmacists per 100 000 population
Abstract
Executive summary
Introduction
Organization and governance
Financing
Physical and human resources
Provision of services
Principal health reforms
Assessment of the health system
1. Introd
uctio
n1. Introduction
1.1 Geography and sociodemography
2ig 11ap o the nited indom
Source: httpwwwmapoucom
3able 11 Trends in populationdemoraphic indicators selected years
10 10 15 2000 2005 2010 2011 2012 201 201Population total 5 52 50 5 0 2 1 5Population emale o total
51 51 51 51 510 50 50 50 50 50
Population rowth annual
01 0 0 0 0 0 0 0 0 0
Population aed 01 o total
210 10 15 10 1 1 15 15 1 1
Population aed 5 and above o total
1 15 15 15 10 1 1 12 15 1
e dependency ratio o worinae population
51 52 55 5 51 51 52 51 50 5
irth rate crude per 1 000 people
1 1 12 115 120 12 12 12 122
eath rate crude per 1 000 people
11 112 111 10 0
Population density people per s m o land area
22 2 2 2 2 25 215 2 250 2
rban population o total
5 1 1 1 1 21 2
Source: orld an 2015
41.2 Economic context
5able 12 acroeconomic indicators selected years
10 10 15 2000 2005 2010 2011 2012 201 201P current S billions
55 1 0 1 2 1 5 2 12 2 0 2 52 2 15 2 2 2
P PPP current international billions
1 00 1 22 1 10 2 05 2 255 2 12 2 1 2 52 2 525
P per capita current S
10 02 1 05 21 2 2 2 5 2 0 5 1 051 1 5 0
P per capita PPP current international
1 5 21 0 2 0 525 5 20 5 255 1
P rowth annual
22 05 25 2 1 1 0 1 2
eneral overnment inal consumption ependiture o P
20 10 11 15 202 21 20 20 201 1
ash surplusdeicit o P
52 2 5 2 55
Ta revenue o P
2 21 25 252 25 25
entral overnment debt total o P
12 2
ndustry value added o P
1 2 2 20 20 210 205 201 1
riculture value added o P
1 15 0 0 0 0 0 0 0
Services etc value added o P
1 22 2
abour orce total millions
2 2 25 0 20 2 2 2
nemployment total o total labour orce modelled O estimate
5 0 5
Per cent at ris o poverty or social eclusion total population
2 22 22 21 2
coeicient 20 20 2 1 02 Real interest rate
1 2 1 5 1 2 1 11 1 12
Oicial echane rate per S period averae
0 0 0 0 05 0 0 0 0 0
Sources: orld an 2015 European ommission 2015
61.3 Political context
71.4 Health status
able 1 ortality and health indicators selected years
10 10 15 2000 2005 2010 2011 2012 201ie epectancy at birth emale years
5 02 12 2 2 2
ie epectancy at birth male years
0 1 5 5 1 2
ie epectancy at birth total years
5 0 0 10 0 10
ortality rate adult emale per 1 000 emale adults
5 1 25 5 1 55 55
ortality rate adult male per 1 000 male adults
11 12 11 10 5 12 5
Source: orld an 2015
8able 1 Healthy years o lie
2005 200 200 200 200 2010 2011 2012eales t birth 55 0 1 5 52 5 t ae 5 11 111 11 11 11 11 11 105ales t birth 2 50 50 50 52 t ae 5 10 10 10 10 10 10 110 105
Source: European ommission 2015
9able 15 Standardied death rates selected years
ndicators 10 10 15 2000 2005 2010ounicable diseasesSR inectious and parasitic diseases all aes per 100 000
2 1 55 5 05
SR tuberculosis all aes per 100 000 1 0 0 0 05 0oncounicable diseases SR diseases o circulatory system all aes per 100 000
50 51 10 202 2112 11
SR malinant neoplasms all aes per 100 000
210 220 201 1 10 10
SR disease o enitourinary system all aes per 100 000
1252 2 10 10 11
SR tracheabronchuslun cancer all aes per 100 000
51 51 2 0 01
SR malinant neoplasm emale breast all aes per 100 000
022 0 10 2 2
SR cancer o the cervi uteri all aes per 100 000
51 1 2 2
SR diabetes all aes per 100 000 10 11 5SR mental disorders diseases o nervous system and sense orans all aes per 100 000
10 22 252 22 52
SR ischaemic heart disease all aes per 100 000
250 215 121 101 101 25
SR cerebrovascular diseases all aes per 100 000
115 15 51 25 5 211
SR diseases o respiratory system all aes per 100 000
115 1102 105 5
SR diseases o diestive system all aes per 100 000
25 20 2 21 5 11
Eternal causes SR transport accidents all aes per 100 000
120 1002 1 5 5
SR suicide and selinlicted inury all aes per 100 000
1 1 1 2
SR symptoms sins and ill deined conditions all aes per 100 000
2 25 2 2 20
Source: HO Reional Oice or Europe 2015 Health or ll httpdataeurowhointhadb
10
able 1 orbidity and actors aectin health status selected years
10 15 2000 2005 2010 2011 2012 201Hospital dischares all neoplasms per 100 000
1 02 01
ncidence o cancer per 100 000 05 520 1 22 52 52 5 ncidence o trachea bronchus and lun cancer per 100 000
5 5 0 0
ncidence o emale breast cancer per 100 000
111 120 1 1 15 155 152
ncidence o cervi uteri cancer per 100 000
1 11 1 0 5
Prevalence o diabetes mellitus 5 5 51 o reular daily smoers in the population aed 15
0 2 2 2 20 20 20 1
Pure alcohol consumption litres per capita aed 15
100 105 115 105 10
Source: HO Reional Oice or Europe 2015
11
able 1 aternal child and adolescent health indicators selected years
10 10 15 2000 2005 2010 2011 2012 201 201 2015dolescent ertility rate births per 1 000 women aed 151
2 1 10 2 2 25 25 25 25
aternal mortality rate national estimate per 100 000 live births
10 11 11 12 11
ortality rate inant per 1 000 live births
120 1 5 51 2 1 5
ortality rate neonatal per 1 000 live births
5 1 5 0 2 2 2 25 2
ortality rate under5 per 1 000 live births
11 2 0 52 50 2
Source: orld an 2015
2. Organization and governance
2.1 Overview of the health system
2.2 Historical background
ig 2
1 Ov
ervie
w o
th
e he
alth
syst
em
Regu
lator
y role
Man
ager
ial re
lation
ship
Finan
cial f
low
s
UK Pa
rliam
ent
NHS
Scot
land
NHS
North
ern
Irelan
d
Scot
tish
Parli
amen
t
Depa
rtmen
t of H
ealth
NI
Mon
itor
MHR
NHS ng
land
en
tral
oer
nmen
tHM
re
asur
y
Pulic
He
alth
ng
land
ar
e
ualit
yom
miss
ion
en
eral
Med
ical
ounc
il
Healt
h an
d So
cial
are
Dire
ctor
ates
Depa
rtmen
t of H
ealth
Socia
l Serice
s an
d Pulic
Sa
fety
Regu
latio
n
uality
Impr
oem
ent
utho
rity
Healt
hcar
e In
spec
tora
te
ales
Healt
hcar
e Im
pro
emen
tSc
otlan
d
NHS
ales
Barn
ett f
orm
ula
Natio
nal
ssemly
for
ales
Min
ister
fo
r He
alth
and
Socia
l Serice
s
North
ern
Irish
ss
emly
rm
slen
gth od
iesRe
gulat
ors
2.3 Organization
United Kingdom Government
NHS in England
NHS in Scotland
NHS in Wales
Health and Social Care in Nor thern Ireland
National Institute for Health and Care Excellence (NICE)
Medicines and Healthcare products Regulator y Agency (MHRA)
Trade unions
Royal colleges
The pr ivate and not-for-profit sectors
2.4 Decentralization and centralization
2.5 Planning
NHS in England
NHS in Scotland
NHS in Wales
Health and Social Care in Nor thern Ireland
2.6 Intersectorality
2.7 Health information management
2.7.1 Information systems
2.7.2 Health technology assessment
2.8 Regulation
2.8.1 Regulation and governance of third party payers
2.8.2 Regulation and governance of providers
England
Scotland
Wales
Nor thern Ireland
2.8.3 Regulation and planning of human resources
2.8.4 Regulation and governance of pharmaceuticals
2.8.5 Regulation of medical devices and aids
2.8.6 Regulation of capital investment
2.9 Patient empowerment
2.9.1 Patient information
2.9.2 Patient choice
2.9.3 Patient rights
2.9.4 Complaints procedures
2.9.5 Public participation
2.9.6 Patients and cross-border health care
3. Financing
3.1 Health expenditure
able 1 Trends in health ependiture in the nited indom 15 to 201
ndicators 15 2000 2005 2010 2011 2012 201Total health ependiture THE ross omestic Product P
1 2 1
Total ependiture on health capita at Purchasin Power Parity per S
1 1 211 22 22 25 11
verae annual rowth rate in per capita ependiture
1 5 00 0 2
Private insurance as o PvtHE 1 1 20 201 11 11 11Private ependiture on health PvtHE as o THE 11 20 1 10 1 10 15Out o pocet ependiture as o THE 10 111 0 Out o pocet ependiture as o PvtHE 5 51 5 5 5 5HE as o eneral overnment ependiture 10 151 152 15 11 12 12eneral overnment ependiture on health as o P
5 55
eneral overnment ependiture on health cap rate
11 1 25 20 00 01 00
eneral overnment ependiture on health cap Purchasin Power Parity per S
110 150 220 20 20 21 2
eneral overnment ependiture on health HE as o THE
1 1 0 0 5
Source: HO 201 HO lobal Health Ependiture atabase
ig 1 Health ependiture as a share o P in the HO European Reion latest available year
Source: HO Reional Oice or Europe 2015
ig 2 Total health ependiture as o P HO estimates
Source: HO Reional Oice or Europe 2015
4
6
8
10
12
EU members since May 2004
EU members before May 2004
EUUnited Kingdom
Sweden
GermanyFrance
2013201220112010200920082007200620052004200320022001200019991998199719961995
ig Health ependiture in PPP per capita in the HO European Reion latest available year
Source: HO Reional Oice or Europe 2015
ig Health ependiture rom public sources as a percentae o total health ependiture in the HO European Reion latest available year
Source: HO Reional Oice or Europe 2015
3.2 Sources of revenue and financial flows
ig 5 inancial lows
HM Treasury
Nationaltaxes
GOVERNMENT
Governmental financing system Private financing system
Transfers within systemOut-of-pocket financing
Clinical commissioning group
Local Authority
Private medical insurance companies
Enterprises
Population
Public health
ERVE PROVER
PRVTE
Mental health
Hospital services
out-o-pocet payments
pecialist services
Private healthcare acilities
Community pharmacies
Primary care
Community service
Local health social care boards
evolved nations
epartment o Health
Public Health England
NH England
3.3 Overview of the statutory financing system
3.3.1 Coverage
3.3.2 Collection
3.3.3 Pooling of funds
England
The Barnett formula
Nor thern Ireland, Scotland and Wales
3.3.4 Purchasing and purchaserprovider relations
3.4 Out-of-pocket payments
3.4.1 Cost-sharing (user charges)
3.4.2 Direct payments
3.5 Voluntary health insurance
3.6 Other financing
3.7 Payment mechanisms
3.7.1 Paying for health services
Payment by Results (PbR) in England
Pay for Per formance (P4P) in England
3.7.2 Paying health workers
GPs
Consultants/Specialists
Junior doctors
Nurses, midwives and other NHS staff
NHS dentistr y
Pharmacists
4. Physical and human resources
4.1 Physical resources
4.1.1 Capital stock and investments
Cur rent capital stock
Investments
4.1.2 Infrastructure
ig 1 Hospital beds by type per 100 000 population 200 200 and 201
Source: HO Reional Oice or Europe 2015
ig 2 cute care hospital beds per 100 000 population
Source: HO Reional Oice or Europe 2015
0
100
200
300
400
500
600
700
800
EU members since May 2004
EU members before May 2004
EU
United KingdomSweden
Germany
France
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1999
1998
1997
1996
1995
1994
1993
1992
1991
1990
ig verae lenth o stay acute care hospitals only
Source: HO Reional Oice or Europe 2015
0
2
4
6
8
10
12
14
EU members since May 2004
EU members before May 2004
EU
United KingdomSweden
Germany
France
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1999
1998
1997
1996
1995
1994
1993
1992
1991
1990
4.1.3 Medical equipment
able 1 ianostic imain in the nited indom 2012
er i ll ion population Eas per 1 000R units 0T scanners 55
Source: OE 201 OE Health at a lance httpwwwoecdilibraryordobserverdownload11211edNote: Eams outside hospital are not included
4.1.4 Information technology
4.2 Human resources
4.2.1 Health workforce trends
ig Physicians per 100 000 population
Source: HO Reional Oice or Europe 2015
0
50
100
150
200
250
300
350
400
450
EU members since May 2004
EU members before May 2004EU
United Kingdom
SwedenGermany
France
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1999
1998
1997
1996
1995
1994
1993
1992
1991
1990
ig 5 urses per 100 000 population
Source: HO Reional Oice or Europe 2015
0
200
400
600
800
1000
1200
1400
EU members since May 2004
EU members before May 2004
EUUnited Kingdom
Germany
France
20132012201120102009200820072006200520042003200220012000
ig Physicians and nurses per 100 000 population
Source: HO Reional Oice or Europe 2015
ig entists per 100 000 population
Source: HO Reional Oice or Europe 2015
0
10
20
30
40
50
60
70
80
90
100
EU members since May 2004
EU members before May 2004EU
United Kingdom
SwedenGermany
France
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1999
1998
1997
1996
1995
1994
1993
1992
1991
1990
ig Pharmacists per 100 000 population
Source: HO Reional Oice or Europe 2015
4.2.2 Professional mobility of health workers
20
40
60
80
100
120
EU members since May 2004
EU members before May 2004EUUnited KingdomSweden
Germany
France
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1999
1998
1997
1996
1995
1994
1993
1992
1991
1990
4.2.3 Training and career paths of health workers
Physicians
Dentists
Nur ses and midwives
Pharmacists
5. Provision of services
5.1 Public health
5.2 Patient pathways
5.3 Primary/ambulatory care
5.4 Specialized ambulatory care/inpatient care
5.5 Emergency care
5.6 Pharmaceutical care
5.7 Rehabilitation/intermediate care
5.8 Long-term care
5.9 Services for informal carers
5.10 Palliative care
5.11 Mental health care
5.12 Dental care
5.13 Complementary and alternative medicine
6. Principal health reforms
6.1 Analysis of recent reforms
England
Nor thern Ireland
Scotland
Wales
6.2 Future developments
England
Nor thern Ireland
Scotland
Wales
7. Assessment of the health system
7.1 Stated objectives of the health system
7.2 Financial protection and equity in financing
7.2.1 Financial protection
7.2.2 Equity in financing
7.3 User experience and equity of access to health care
7.3.1 User experience
7.3.2 Equity of access to health care
7.4 Health outcomes, health service outcomes and quality of care
7.4.1 Population health
7.4.2 Health service outcomes and quality of care
7.5 Health system efficiency
7.5.1 Allocative efficiency
7.5.2 Technical efficiency
7.6 Transparency and accountability
8. Conclusions
9. Appendices
9.1 References
Workforce planning in the NHS
Public payment and private provision: The changing landscape of healthcare in the 2000s
Best practice tariffs and their impact
Accident and Emergency Statistics
Social care cap to be set at 75,000
Edwin Poots: Prescription charges could buy cancer drugs
Scotland Decides
The four health systems of the United Kingdom: how do they compare
Four hundred-plus deprived area GP practices face MPIG withdrawal
General Practitioners Committee: MPIG Changes
Pay for doctors
BMA Annual Report Financial Statements for the year ended 31 December 2014
). EWTD for junior doctors
Out-of-hours care
Personal Medical Services (PMS) Agreements
. Health Systems in Transition
Delayed discharges in England reach record high
The Mortality Effects of Long-Term Exposure to Particulate Air Pollution in the United Kingdom.
BMJ Mirror, Mirror On The Wall: How the
Performance of the U.S. Health Care System Compares Internationally
Code of Conduct for Payment by Results in 201314
Government agrees breakthrough drug pricing deal with pharmaceutical firms
The Mandate explained
Hard Truths: The Journey to Putting Patients First
NHS buildings: obstacle or opportunity
Whats behind the drop in A&E performance
Health inequalities in the EU Final report of a consortium
Eurostat Database
Integrated care in Northern Ireland, Scotland and Wales: Lessons for England
The NHS under the coalition government. Part one: NHS reform
Integrated Care Partnerships
The Barnett Formula
Pulse
An alternative guide to the new NHS in England.
The New NHS
Medical workforce
The Francis Inquiry report.
Making best use of the Better Care Fund
The UK private health market
). Whats going on in A&E? The key questions answered
Health Systems in TransitionNews
Letter
Public Money and ManagementThe Better Care Fund: do the sums add up?
The NHS payment system: evolving policy and emerging evidence.
The Lancet
Financial failure in the NHS: What causes it and how best to manage it.
Pay Modernisation: A New Contract for NHS Consultants in England
The National Programme for IT in the NHS: an update on the delivery of detailed care records systems
The financial sustainability of NHS bodies
Palliative Care Explained
The Operating Framework for the NHS in England 2012/13
Complaints about the NHS up by 8%.
How much will I pay for NHS dental treatment
Patient choice of GP practices
Key statistics on the NHS
Quality and outcomes framework
NHS England Business Case Approvals Process for Capital Investment, Property, Equipment and ICT
Transforming Participation in Health and Care
Transforming Participation in Health and Care, Guidance for Commissioners
Commissioning for Quality and Innovation (CQUIN): 2014/15 guidance. London, NHS England
NHS England publishes outcomes of GP Personal Medical Services review. London, NHS England
Technical Guide to the formulae for 201415 and 201516 revenue allocations to Clinical Commissioning Groups and Area Teams
Understanding the new NHS.
NHS standard contract
Working in the NHS
The Healthcare Quality Strategy for NHS Scotland
Public and Patient Involvement and Experience in NHS Wales
Pharmaceutical spending. London, Organisation for Economic Co-operation and Development
Health at a Glance 2013: OECD indicators
Health at a glance: Europe 2014.
Health at a glance 2015: OECD indicators
. Health Systems in Transition,Table 2 2011 Census: Usual resident population and population density, local
authorities in the United Kingdom
Internet Access Households and Individuals, 2014.
Mortality in the United Kingdom, 19832013
Public Sector Employment, Q2 2014
Trend in life expectancy at birth and at age 65 by socioeconomic position based on the National Statistics Socio-economic Classification, England and Wales, 19821986 to 20072011
). Personal and Public Involvement (PPI).
Tuberculosis (TB) in the UK: annual report
Bulletin of the World Health Organization
BMJ
The 2022 GP Compendium of Evidence
About the Act
Patient Focus and Public Involvement
Waiting times in NHS at worst for six years The Telegraph
Tory MP Redwood leads calls for English Parliament
Health Systems in Transition
The LancetThe future of devolution in Wales
New system for emergency ambulance services to prioritise patients in most need of care.
European Health for All database
The Telegraph
World Development Indicators Online (WDI) database
9.2 Useful web sites
Agenda for Change: http://wwwnhsemployersorg/your-workforce/pay-and-reward/pay/agenda-for -change-pay/how-agenda-for-change-works
Br itish Medical Association: http://bmaorguk/
General Medical Council: http://wwwgmc-ukorg/about/UK_health_and_social_care_regulatorsasp
Healthcare Improvement Scotland: http://wwwhealthcareimprovementscotlandorg/about_usaspx
HSCIC: http://wwwhscicgovuk/suppor tandguidance
Independent Community Pharmacist: http://wwwindependentpharmacistcouk/aboutuscfm
Integrated Care and Suppor t Exchange: http://wwwicaseorguk/pg/dashboard
MATCH: http://wwwmatchacuk/
MHRA: https://wwwgovuk/government/organisations/medicines-and-healthcare-products-regulator y-agency/about
NHS Choices: http://wwwnhsuk/Pages/HomePageaspx
NHS Direct Wales: http://wwwnhsdirectwalesnhsuk/
NICE: http://wwwniceorguk/
NI Direct: http://wwwnidirectgovuk/
NIHR: http://wwwnihracuk/
Office for National Statistics: http://wwwonsgovuk/ons/indexhtml
Pr ivate Healthcare UK: http://wwwpr ivatehealthcouk/health-insurance/
RQIA: http://wwwrqiaorguk/home/indexcfmThe Scottish Char ter of Patient Rights and Responsibilities: http://wwwgovscot/Resource/0039/00390989pdf
SHOW Scotland: http://wwwshowscotnhsuk/
Spine Ser vices: http://systemshscicgovuk/spine
Universal Credit: http://wwwnhsuk/NHSEngland/Healthcosts/Pages/univer sal-creditaspx
9.3 HiT methodology and production process
9.4 The review process
9.5 About the authors
Jonathan Cylus
Er ica Richardson
Lisa Findley
Marcus Longley
Ciaran ONeill
David Steel
The Health Systems in Transition profiles
A series of the European Observatory on Health Systems and Policies
How to obtain a HiT
Eurohealth
info@obseurowhoint
www.healthobservatory.eu
Albania (1999, 2002a)Andor r a (2004)Armenia (2001, 2006, 2013)Austr alia (2002, 2006)Austr ia (2001e, 2006e, 2013)Azerbaijan (2004, 2010)Belarus (2008, 2013)Belgium (2000, 2007, 2010)Bosnia and Herzegovina (2002)Bulgar ia (1999, 2003b, 2007, 2012b)Canada (2005, 2013c)Croatia (1999, 2006, 2014)Cypr us (2004, 2012)Czech Republic (2000, 2005, 2009, 2015)Denmark (2001, 2007, 2012)Estonia (2000, 2004, 2008, 2013)Finland (2002, 2008)France (2004c, 2010, 2015)Georgia (2002d, 2009)Ger many (2000e, 2004e, 2014e)Greece (2010)Hungar y (1999, 2004, 2011)Iceland (2003, 2014)Ireland (2009)Israel (2003, 2009)Italy (2001, 2009)Japan (2009)Kazakhstan (1999, 2007, 2012)Kyrgyzstan (2000, 2005, 2011)Latvia (2001, 2008, 2012)Lithuania (2000, 2013)Luxembourg (1999)Malta (1999, 2014) Mongolia (2007)Nether lands (2004, 2010)New Zealand (2001)Nor way (2000, 2006, 2013)Poland (1999, 2005, 2012)Por tugal (1999, 2004, 2007, 2011)
Republic of Korea (2009)Republic of Moldova (2002, 2008, 2012)Romania (2000, 2008)Russian Federation (2003, 2011)Slovakia (2000, 2004, 2011)Slovenia (2002, 2009)Spain (2000h, 2006, 2010)Sweden (2001, 2005, 2012)Switzer land (2000, 2015)Tajikistan (2000, 2010l)The former Yugoslav Republic of
Macedonia (2000, 2006)Turkey (2002i, 2011)Turkmenistan (2000)Ukraine (2004, 2010, 2015)United Kingdom of Great Br itain and
Nor ther n Ireland (1999)United Kingdom (England) (2011)United Kingdom (Nor thern Ireland) (2012)United Kingdom (Scotland) (2012)United Kingdom (Wales) (2012)United States of Amer ica (2013)Uzbekistan (2001, 2007, 2014)Veneto Region, Italy (2012)
e
ll HiTs are available in Enlishhen noted they are also available in other lanuaesa lbanian
b ularian
c rench
d eorian
e erman
Romanian Russian
h Spanish
i Turish Estonian Polish
l Tai
HiT country profiles published to date:
ISSN
1817
-61
27
The
Euro
pean
Ob
serv
ator
y on
Healt
h Sys
tem
s an
d Poli
cies
is a
partn
ersh
ip, ho
sted b
y the
W
HO Re
giona
l Offi
ce fo
r Eur
ope,
w
hich
in
clude
s th
e Go
vern
men
ts of
Au
stria,
Be
lgium
,
Finlan
d, Ire
land,
Norw
ay, Slo
veni
a, Sw
eden
, th
e Un
ited K
ingd
om an
d the
Ve
neto
Re
gion
of Ita
ly; th
e Eu
rope
an Co
mm
issio
n; th
e W
orld
Ba
nk; U
NCAM
(Fr
ench
Na
tiona
l Uni
on of
He
alth
Insu
ranc
e Fu
nds);
the
Lond
on Sc
hool
of
Ec
onom
ics an
d Poli
tical
Scien
ce; a
nd th
e Lo
ndon
Sc
hool
of
Hy
giene
&
Trop
ical M
edici
ne. Th
e Eu
rope
an Ob
serv
ator
y has
a
secr
etar
iat in
Br
usse
ls an
d it h
as hu
bs in
Lo
ndon
(at
LS
E and
LS
HTM
) and a
t the
Te
chni
cal U
nive
rsity
of
Be
rlin.
HiTs
ar
e in
-de
pth p
rofil
es of
he
alth s
yste
ms
and p
olicie
s, pr
oduc
ed us
ing a
sta
ndar
dize
d app
roac
h tha
t allo
ws
com
paris
on ac
ross
co
untri
es. Th
ey pr
ovid
e fac
ts, fig
ures
an
d ana
lysis
and
high
light
re
form
in
itiat
ives
in pr
ogre
ss.